Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Shilpa Medicare Limited (NSE: SHILPAMED), ISIN INE790G01031 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
SHILPAMED last traded at ₹1046.20 (+0.88%), with a 52-week range of ₹260.00 to ₹1075.75 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 40.13%, FIIs 11.38%, DIIs 8.05%, mutual funds 4.21%.
EquiSense Score (ECS): 84/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.